Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comparative study of PCS and PAM50 prostate cancer classification schemes. | Prostate Cancer Prostatic Dis | 2021 | 33531653 | PubTator, text mining | PubMed |
| Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells. | Int J Mol Sci | 2021 | 33513992 | PubTator, text mining | PubMed |
| Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. | Arch Toxicol | 2021 | 33512557 | PubTator, text mining | PubMed |
| Development of a novel hyaluronic acid membrane for the treatment of ocular surface diseases. | Sci Rep | 2021 | 33504908 | PubTator, text mining | PubMed |
| Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment? | Cancers (Basel) | 2021 | 33498676 | PubTator, text mining | PubMed |
| Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. | Cancers (Basel) | 2021 | 33494389 | PubTator, text mining | PubMed |
| SARS-COV-2 infection and lung tumor microenvironment. | Mol Biol Rep | 2021 | 33486674 | PubTator, text mining | PubMed |
Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway. | Cancer Cell Int | 2021 | 33407495 | PubTator, text mining | PubMed |
| Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells. | Biomedicines | 2021 | 33406809 | PubTator, text mining | PubMed |
| Dichloroacetate attenuates the stemness of hepatocellular carcinoma cells via promoting nucleus-cytoplasm translocation of YAP. | Environ Toxicol | 2021 | 33405312 | PubTator, text mining | PubMed |
| Prognostic implication of glycolysis related gene signature in non-small cell lung cancer. | J Cancer | 2021 | 33403045 | PubTator, text mining | PubMed |
| Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry. | JCI Insight | 2021 | 33400685 | PubTator, text mining | PubMed |
| Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier. | Adv Mater | 2021 | 33326131 | PubTator, text mining | PubMed |
| A replicating stem-like cell that contributes to bone morphogenetic protein 2-induced heterotopic bone formation. | Stem Cells Transl Med | 2021 | 33245845 | PubTator, text mining | PubMed |
| The phenotypic and transcriptomic effects of developmental exposure to nanomolar levels of estrone and bisphenol A in zebrafish. | Sci Total Environ | 2021 | 33243503 | PubTator, text mining | PubMed |
| Polyphyllin VII suppresses cell proliferation, the cell cycle and cell migration in colorectal cancer. | Oncol Lett | 2021 | 33240431 | PubTator, text mining | PubMed |
| The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer. | J Mol Histol | 2021 | 33141360 | PubTator, text mining | PubMed |
| The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases. | Cardiovasc Eng Technol | 2021 | 32959164 | PubTator, text mining | PubMed |
| 4-Methylumbelliferone as a potent and selective antitumor drug on a glioblastoma model. | Glycobiology | 2021 | 32472122 | PubTator, text mining | PubMed |
| CD44 and RHAMM expression patterns in the human developing lung. | Pediatr Res | 2021 | 32311697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=45